SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL) -- Ignore unavailable to you. Want to Upgrade?

To: TheAlaskan who wrote (320)2/26/1999 7:06:00 AM
From: CPAMarty  Respond to of 2515
 
At the risk of being overly optimistic, i don't think it is possible for IMCL to break out past resistance at $13 very soon. Similar biotechs which are not as far along in clinical trials trade at much higher prices.
And as the recent articles point out, significant revenues may be realized in the very near (relative to most biotech investments) future.
IMHO, $20 SOON!!!!!!



To: TheAlaskan who wrote (320)2/26/1999 2:15:00 PM
From: JEB  Respond to of 2515
 
You and I both know IMCL is way stronger than ENMD. Personally, I do not see a comparison. -JMHO-

Thanks,
JEB


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News